ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2017
STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.
Open access · goldAbstract read
In one paragraph
Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.
- Cognitive impairment before and after intracerebral haemorrhage: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020Pooled it
- Long-Term Post-Stroke Cognition in Patients With Minor Ischemic Stroke is Related to Tract-Based Disconnection Induced by White Matter Hyperintensities.Human brain mapping · 2025Article
- Network analysis of neuropsychiatric, cognitive, and functional complications of stroke: implications for novel treatment targets.Psychiatry and clinical neurosciences · 2024Article
- National and international collaborations to advance research into vascular contributions to cognitive decline.Cerebral circulation - cognition and behavior · 2024Article
- Disentangling poststroke cognitive deficits and their neuroanatomical correlates through combined multivariable and multioutcome lesion-symptom mapping.Human brain mapping · 2023Article
- Mental health care for older adults: recent advances and new directions in clinical practice and research.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2022Article
- Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study.Neurology and therapy · 2022Article
- Ischemic stroke demographics, clinical features and scales and their correlations: an exploratory study from Jordan.Future science OA · 2022Article
- The Cognitive Sequelae of Transient Ischemic Attacks-Recent Insights and Future Directions.Journal of clinical medicine · 2022Review
- Impact of Small Vessel Disease Progression on Long-term Cognitive and Functional Changes After Stroke.Neurology · 2022Article
- Is Frailty Index a better predictor than pre-stroke modified Rankin Scale for neurocognitive outcomes 3-months post-stroke?BMC geriatrics · 2022Article
- Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022Review
- Vascular Cognitive Impairment (VCI).Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022Review
- Research protocol - Assessing Post-Stroke Psychology Longitudinal Evaluation (APPLE) study: A prospective cohort study in stroke.Cerebral circulation - cognition and behavior · 2022Article
- Testing a convolutional neural network-based hippocampal segmentation method in a stroke population.Human brain mapping · 2022Article
- Dementia in Southeast Asia: influence of onset-type, education, and cerebrovascular disease.Alzheimer's research & therapy · 2021Article
- Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study.Stroke · 2021Review
- Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee.European stroke journal · 2021Review
- Elevated Circulating Microparticle Subpopulations in Incidental Cerebral White Matter Hyperintensities: A Multimodal Study.Brain sciences · 2021Article
- Cilostazol and Probucol for Cognitive Decline after Stroke: A Cognitive Outcome Substudy of the PICASSO Trial.Journal of stroke · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
68 authors at 20 institutions in 14 countries.
Perminder S SachdevCentre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia; Dementia Collaborative Research Centre, University of New South Wales, Sydney, Australia.
Jessica W LoCentre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia.
John D CrawfordCentre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia.
Lisa MellonDepartment of Psychology, Royal College of Surgeons in Ireland, Dublin, Ireland.
Anne HickeyDepartment of Psychology, Royal College of Surgeons in Ireland, Dublin, Ireland.
David WilliamsDepartment of Stroke and Geriatric Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Régis BordetUniversity of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
Anne-Marie MendykUniversity of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
Patrick GeléUniversity of Lille, Inserm, CHU Lille, CIC 1403 - Centre d'investigation clinique, Lille, France.
Dominique DeplanqueUniversity of Lille, Inserm, CHU Lille, CIC 1403 - Centre d'investigation clinique, Lille, France.
Hee-Joon BaeDepartment of Neurology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; Clinical Neuroscience Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Jae-Sung LimDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Amy BrodtmannFlorey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
Emilio WerdenFlorey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
Toby CummingFlorey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
Sebastian KöhlerSchool for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Frans R J VerheySchool for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Yan-Hong DongCentre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia; Dementia Collaborative Research Centre, University of New South Wales, Sydney, Australia; Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Medicine (Neurology Division), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Hui Hui TanMemory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Medicine (Neurology Division), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Christopher ChenMemory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Xu XinMemory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Raj N KalariaNeurovascular Research Group, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Louise M AllanNeurovascular Research Group, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Rufus O AkinyemiNeuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training College of Medicine, University of Ibadan, Ibadan, Nigeria.
Adesola OgunniyiNeuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training College of Medicine, University of Ibadan, Ibadan, Nigeria; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Aleksandra Klimkowicz-MrowiecDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Martin DichgansInstitute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Frank A WollenweberInstitute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany.
Vera ZietemannInstitute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany.
Michael HoffmannCognitive Neurology and Stroke Programs, University of Central Florida, Orlando VA Medical Center, Orlando, Florida, USA.
David W DesmondNo Affiliation.
Thomas LindenFlorey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia; Institute of Neuroscience and Physiology, Centre of Brain Research and Rehabilitation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Hunter Medical Research Institute, Newcastle, NSW, Australia.
Christian BlomstrandInstitute of Neuroscience and Physiology, Centre of Brain Research and Rehabilitation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Björn FagerbergDepartment of Molecular and Clinical Medicine, Wallenberg Laboratory for Cardiovascular and Metabolic Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ingmar SkoogInstitute of Neuroscience and Physiology, Center for Health and Ageing AGECAP, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Olivier GodefroyDepartment of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France.
Mélanie BarbayDepartment of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France.
Martine RousselDepartment of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France.
Byung-Chul LeeDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Kyung-Ho YuDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
Joanna WardlawCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Stephen J MakinInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
Fergus N DoubalCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Francesca M ChappellCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Velandai K SrikanthPeninsula Clinical School, Central Clinical School, Monash University, Melbourne, Australia; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.
Amanda G ThriftDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea; Peninsula Clinical School, Central Clinical School, Monash University, Melbourne, Australia.
Geoffrey A DonnanFlorey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
Nagaendran KandiahDepartment of Neurology, National Neuroscience Institute, Singapore.
Russell J ChanderDepartment of Neurology, National Neuroscience Institute, Singapore.
Xuling LinDepartment of Neurology, National Neuroscience Institute, Singapore.
Charlotte CordonnierUniversity of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
Solene MoulinUniversity of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
Costanza RossiUniversity of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
Behnam SabayanDepartment of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands.
David J StottAcademic Section of Geriatrics, University of Glasgow, Glasgow, United Kingdom.
J Wouter JukemaDepartment of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands.
Susanna MelkasClinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, Finland.
Hanna JokinenClinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, Finland.
Timo ErkinjunttiClinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, Finland.
Vincent C T MokDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Hong Kong SAR, China.
Adrian WongDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Hong Kong SAR, China.
Bonnie Y K LamDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Hong Kong SAR, China.
Didier LeysUniversity of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
Hilde HénonUniversity of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
Stéphanie BomboisUniversity of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
Darren M LipnickiCentre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia.
Nicole A KochanCentre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia.
STROKOG
Inserm · FRUniversity of Gothenburg · SEFlorey Institute of Neuroscience and Mental Health · AUHallym University Sacred Heart Hospital · KRUniversité de Lille · FRUNSW Sydney · AUCentre Hospitalier Universitaire Amiens-Picardie · FRChinese University of Hong Kong · HKNational Neuroscience Institute · SGNational University of Singapore · SGRoyal College of Surgeons in Ireland · IEUniversity of Edinburgh · GBDementia Collaborative Research Centres · AUHelsinki University Hospital · FILeiden University · NLLudwig-Maximilians-Universität München · DEMaastricht University · NLNewcastle University · GBUniversity of Ibadan · NGCentre Hospitalier Universitaire de Lille · FR
Funding
VASCULAR FACTORS AND MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASEP01AG007232 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LUCHSINGER, JOSE ALEJANDRO · 1989 to 2008
$21.7MMedical Research Council G0400074Medical Research Council G0500247Medical Research Council G0502157Medical Research Council G0700718Medical Research Council G0900652Medical Research Council G1100540Medical Research Council MR/K026992/1NIA NIH HHS P01 AG007232Wellcome Trust
Abstract
introductionThe Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).
methodsLongitudinal studies with ≥75 participants who had suffered or were at risk of stroke or TIA and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia.
resultsCurrently, STROKOG includes 25 (21 published) studies, with 12,092 participants from five continents. The duration of follow-up ranges from 3 months to 21 years. DISCUSSION: Although data harmonization will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.
Indexed as
Cohort studiesData harmonizationInternational consortiumPost-stroke dementiaSmall vessel diseaseVascular cognitive disorderVascular dementia
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.